We are live on ! Find out more
MSA

Marino Stram & Associates Portfolio holdings

AUM $628M
1-Year Est. Return 23.07%
This Fund
S&P 500
This Quarter Est. Return
+4.59%
1 Year Est. Return
+23.07%
3 Year Est. Return
+63.64%
5 Year Est. Return
+76.05%
10 Year Est. Return
AUM
$331M
AUM Growth
+$13.6M
Cap. Flow
+$5.44M
Cap. Flow %
1.64%
Top 10 Hldgs %
58.63%
Holding
159
New
6
Increased
88
Reduced
42
Closed
4

Sector Composition

Rank Sector Weight
1 Healthcare 5.74%
2 Technology 5.6%
3 Consumer Staples 4.77%
4 Consumer Discretionary 4.49%
5 Financials 4.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VYM icon
1
Vanguard High Dividend Yield ETF
VYM
$80.9B
$51.3M 15.49%
486,254
+3,293
+0.7% +$354K
SDY icon
2
State Street SPDR S&P Dividend ETF
SDY
$21.7B
$32.6M 9.85%
263,486
-289
-0.1% -$36.4K
IVV icon
3
iShares Core S&P 500 ETF
IVV
$878B
$31.5M 9.5%
76,523
+588
+0.8% +$236K
VTV icon
4
Vanguard Morningstar Value ETF
VTV
$188B
$19.5M 5.9%
141,399
+1,311
+0.9% +$184K
VUG icon
5
Vanguard Morningstar Growth ETF
VUG
$220B
$12.8M 3.86%
307,536
+1,314
+0.4% +$51.1K
IJR icon
6
iShares Core S&P Small-Cap ETF
IJR
$109B
$12.3M 3.72%
127,492
+880
+0.7% +$88K
IJH icon
7
iShares Core S&P Mid-Cap ETF
IJH
$122B
$12.2M 3.69%
244,435
+1,750
+0.7% +$89.2K
AAPL icon
8
Apple
AAPL
$4.54T
$8.16M 2.47%
49,506
-2,929
-6% -$432K
DKNG icon
9
DraftKings
DKNG
$11.6B
$7.53M 2.27%
+389,021
New +$6.47M
MSFT icon
10
Microsoft
MSFT
$3.45T
$6.19M 1.87%
21,486
-813
-4% -$207K
JNJ icon
11
Johnson & Johnson
JNJ
$618B
$4.21M 1.27%
27,136
-9,764
-26% -$1.58M
MRK icon
12
Merck
MRK
$322B
$3.89M 1.17%
36,521
+204
+0.6% +$22K
AOR icon
13
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.66B
$3.69M 1.11%
73,775
JPM icon
14
JPMorgan Chase
JPM
$935B
$3.63M 1.1%
27,880
+347
+1% +$47.5K
PEP icon
15
PepsiCo
PEP
$190B
$3.27M 0.99%
17,931
-423
-2% -$73.9K
LMT icon
16
Lockheed Martin
LMT
$134B
$3.07M 0.93%
6,493
+94
+1% +$44.1K
NULV icon
17
Nuveen ESG Large-Cap Value ETF
NULV
$2.19B
$2.87M 0.87%
84,352
+6,215
+8% +$214K
PG icon
18
Procter & Gamble
PG
$336B
$2.85M 0.86%
19,140
-38
-0.2% -$5.43K
MCD icon
19
McDonald's
MCD
$192B
$2.78M 0.84%
9,941
-59
-0.6% -$15.8K
PFE icon
20
Pfizer
PFE
$143B
$2.69M 0.81%
65,939
+949
+1% +$41K
BRK.B icon
21
Berkshire Hathaway Class B
BRK.B
$1.1T
$2.5M 0.76%
8,101
+243
+3% +$74.9K
KO icon
22
Coca-Cola
KO
$377B
$2.44M 0.74%
39,372
+380
+1% +$23K
USMV icon
23
iShares MSCI USA Min Vol Factor ETF
USMV
$23.5B
$2.43M 0.73%
33,349
-140
-0.4% -$10.1K
IDV icon
24
iShares International Select Dividend ETF
IDV
$8.45B
$2.31M 0.7%
83,975
-10,378
-11% -$292K
VIG icon
25
Vanguard Dividend Appreciation ETF
VIG
$111B
$2.31M 0.7%
14,983
-2,159
-13% -$331K

Similar funds

Marino Stram & Associates's Q1 2023 Portfolio in Review

As of Q1 2023, Marino Stram & Associates held 159 positions worth $331M, up 4.3% from $317M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Marino Stram & Associates's Q1 2023 filing shows 6 new, 88 increased, 42 reduced and 4 closed positions. Its largest new stake was DraftKings: 389,021 shares worth $7.53M. The largest sale was Johnson & Johnson, an estimated $1.58M.

By sector, the portfolio is most concentrated in Healthcare at 5.7% of assets, down from 7% a quarter earlier, followed by Technology and Consumer Staples.

  • Marino Stram & Associates's largest Q1 2023 buy was DraftKings: 389,021 shares worth $7.53M.
  • Marino Stram & Associates added most to iShares 0-1 Year Treasury Bond ETF in Q1 2023, an estimated $392K increase.
  • Marino Stram & Associates's biggest Q1 2023 reduction was Johnson & Johnson, cutting an estimated $1.58M.
  • Marino Stram & Associates fully exited Akamai in Q1 2023, selling an estimated $496K.
  • Marino Stram & Associates's ten largest holdings make up 59% of its $331M portfolio in Q1 2023.
  • Marino Stram & Associates opened 6 new positions and closed 4 in Q1 2023.
  • Marino Stram & Associates's portfolio value rose 4.3% quarter-over-quarter to $331M.

Based on Marino Stram & Associates's 13F filing for Q1 2023, filed 20 Apr 2023.